Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Key insights about the ZEUS trial | GLP-1 drugs & AFib | Insulin pumps recalled | SAVR bests TAVR in younger patients
Friday, November 13, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Researcher shares key insights after ZEUS trial delivers neutral result

The greater cardiology community was hopeful ZEUS could open the door for significant improvements in patient care. After the trial failed to deliver on that promise, it's time to consider where things went wrong. 

READ MORE >
Paul Ridker, MD, MPH, director of the Center for Cardiovascular Disease Prevention at Brigham and Women's Hospital, and a Professor of Medicine at Harvard School of Medicine presented the late-breaking ZEUS trial that evaluated Ziltivekimab, a new interleukin-6 (IL-6) inhibitor to lower coronary inflammation. While it lowered inflammation, it did not change cardiovascular event outcomes compared to placebo.
Share on Twitter Share on Facebook Share on Linkedin

Researcher shares key insights after ZEUS trial delivers neutral result

Share on Twitter Share on Facebook Share on Linkedin
Paul Ridker, MD, MPH, director of the Center for Cardiovascular Disease Prevention at Brigham and Women's Hospital, and a Professor of Medicine at Harvard School of Medicine presented the late-breaking ZEUS trial that evaluated Ziltivekimab, a new interleukin-6 (IL-6) inhibitor to lower coronary inflammation. While it lowered inflammation, it did not change cardiovascular event outcomes compared to placebo.
The greater cardiology community was hopeful ZEUS could open the door for significant improvements in patient care. After the trial failed to deliver on that promise, it's time to consider where things went wrong. 
READ MORE >

Semaglutide linked to lower AFib risk—other GLP-1 drugs appear to fall short

GLP-1 receptor agonists have been associated with a wide range of potential benefits for patients with and without type 2 diabetes. The team behind this new meta-analysis hoped to learn more about how the popular medications may impact a person's risk of new-onset AFib.

READ MORE >
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
Share on Twitter Share on Facebook Share on Linkedin

Semaglutide linked to lower AFib risk—other GLP-1 drugs appear to fall short

Share on Twitter Share on Facebook Share on Linkedin
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
GLP-1 receptor agonists have been associated with a wide range of potential benefits for patients with and without type 2 diabetes. The team behind this new meta-analysis hoped to learn more about how the popular medications may impact a person's risk of new-onset AFib.
READ MORE >

More than 80,000 insulin pumps recalled due to safety risk—patients should follow latest instructions

The FDA has categorized this as a Class I recall. However, patients can still use the devices as long as they follow specific instructions provided by the manufacturer. 

READ MORE >
Tandem Mobi Insulin Pump
Share on Twitter Share on Facebook Share on Linkedin

More than 80,000 insulin pumps recalled due to safety risk—patients should follow latest instructions

Share on Twitter Share on Facebook Share on Linkedin
Tandem Mobi Insulin Pump
The FDA has categorized this as a Class I recall. However, patients can still use the devices as long as they follow specific instructions provided by the manufacturer. 
READ MORE >

Heart surgery outperforms TAVR in new 5-year study of young, low-risk patients

In-hospital outcomes were slightly better for patients treated with TAVR, but the five-year data linked SAVR to key benefits.

READ MORE >
elderly patient and doctor
Share on Twitter Share on Facebook Share on Linkedin

Heart surgery outperforms TAVR in new 5-year study of young, low-risk patients

Share on Twitter Share on Facebook Share on Linkedin
elderly patient and doctor
In-hospital outcomes were slightly better for patients treated with TAVR, but the five-year data linked SAVR to key benefits.
READ MORE >

Featured Articles

FDA approves stroke prevention devices used during transcarotid artery revascularization

Contego Medical secured the new approvals after the FDA reviewed positive data from the PERFORMANCE III IDE study.

READ MORE >
Contego Medical's Neuroguard IEP Direct System for carotid stenting.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves stroke prevention devices used during transcarotid artery revascularization

Share on Twitter Share on Facebook Share on Linkedin
Contego Medical's Neuroguard IEP Direct System for carotid stenting.
Contego Medical secured the new approvals after the FDA reviewed positive data from the PERFORMANCE III IDE study.
READ MORE >

Cardiologist explains why TAVR may be beneficial for select patients with moderate aortic stenosis

Cardiologist Philippe Généreux spoke to Cardiovascular Business about the highly anticipated PROGRESS trial. "What we learned from this trial is that moderate aortic stenosis should not be seen anymore as a benign entity," he said. 

READ MORE >
Philippe Genereux, MD, Atlantic Health Morristown Medical Center, explains the late-breaking PROGRESS Trial and why TAVR should be done earlier in moderate aortic stenosis patients. #TCT2026 #TAVR
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist explains why TAVR may be beneficial for select patients with moderate aortic stenosis

Share on Twitter Share on Facebook Share on Linkedin
Philippe Genereux, MD, Atlantic Health Morristown Medical Center, explains the late-breaking PROGRESS Trial and why TAVR should be done earlier in moderate aortic stenosis patients. #TCT2026 #TAVR
Cardiologist Philippe Généreux spoke to Cardiovascular Business about the highly anticipated PROGRESS trial. "What we learned from this trial is that moderate aortic stenosis should not be seen anymore as a benign entity," he said. 
READ MORE >

Missing cardiologist found dead near cow pasture

The Massachusetts clinician went missing after going on an afternoon bike ride. Authorities found his body the following day.

READ MORE >
candles funeral dead respect
Share on Twitter Share on Facebook Share on Linkedin

Missing cardiologist found dead near cow pasture

Share on Twitter Share on Facebook Share on Linkedin
candles funeral dead respect
The Massachusetts clinician went missing after going on an afternoon bike ride. Authorities found his body the following day.
READ MORE >

How AI-enabled CCTA assessments help cardiologists and radiologists fight back against plaque

More and more clinicians are using advanced CCTA technologies to diagnose, treat and manage patients with suspected coronary artery disease. An upcoming webinar will include a deep dive into that very topic, highlighting why the modality is such a game-changer for patient care. 

READ MORE >
cardiologists heart doctors
Share on Twitter Share on Facebook Share on Linkedin

How AI-enabled CCTA assessments help cardiologists and radiologists fight back against plaque

Share on Twitter Share on Facebook Share on Linkedin
cardiologists heart doctors
More and more clinicians are using advanced CCTA technologies to diagnose, treat and manage patients with suspected coronary artery disease. An upcoming webinar will include a deep dive into that very topic, highlighting why the modality is such a game-changer for patient care. 
READ MORE >

In Case You Missed It

FDA approves Pascal Precision system from Edwards Lifesciences for tricuspid valve repair

Clinicians have been using this device to perform M-TEER for years. After this latest announcement, it is now officially approved for both mitral valve repair and tricuspid valve repair.

READ MORE >
Pascal Precision T-TEER device from Edwards Lifesciences
Share on Twitter Share on Facebook Share on Linkedin

FDA approves Pascal Precision system from Edwards Lifesciences for tricuspid valve repair

Share on Twitter Share on Facebook Share on Linkedin
Pascal Precision T-TEER device from Edwards Lifesciences
Clinicians have been using this device to perform M-TEER for years. After this latest announcement, it is now officially approved for both mitral valve repair and tricuspid valve repair.
READ MORE >

Medtronic gains CE mark for next-gen portfolio of conduction system pacemakers

These pacemakers were built with conduction system pacing in mind, giving clinicians several new tools for the management of heart patients. 

READ MORE >
Medtronic booth at HRS 2026
Share on Twitter Share on Facebook Share on Linkedin

Medtronic gains CE mark for next-gen portfolio of conduction system pacemakers

Share on Twitter Share on Facebook Share on Linkedin
Medtronic booth at HRS 2026
These pacemakers were built with conduction system pacing in mind, giving clinicians several new tools for the management of heart patients. 
READ MORE >

FDA clears Elucid's new AI-enabled FFR-CT software

According to Elucid, the development of its FFR-IQ software was guided by clinician feedback.

READ MORE >
The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for Elucid's FFR-IQ software for the noninvasive estimation of fractional flow reserve from coronary CT angiography (FFR-CT). The artificial intelligence (AI) based technology incorporates coronary anatomy and plaque composition into its estimation of coronary physiology for a more accurate and individualized assessment to aid in treatment decisions.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears Elucid's new AI-enabled FFR-CT software

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for Elucid's FFR-IQ software for the noninvasive estimation of fractional flow reserve from coronary CT angiography (FFR-CT). The artificial intelligence (AI) based technology incorporates coronary anatomy and plaque composition into its estimation of coronary physiology for a more accurate and individualized assessment to aid in treatment decisions.
According to Elucid, the development of its FFR-IQ software was guided by clinician feedback.
READ MORE >

In Other News

Ōura buys AI-enhanced primary care network for $625M in cash

Once finalized, Counsel Health will see its technology integrated into the Oura application, with an emphasis on improving the management of chronic conditions and monitoring patients for acute emergencies, based on biometrics gathered by smart rings.

READ MORE >
Smart Ring
Share on Twitter Share on Facebook Share on Linkedin

Ōura buys AI-enhanced primary care network for $625M in cash

Share on Twitter Share on Facebook Share on Linkedin
Smart Ring
Once finalized, Counsel Health will see its technology integrated into the Oura application, with an emphasis on improving the management of chronic conditions and monitoring patients for acute emergencies, based on biometrics gathered by smart rings.
READ MORE >

Four states sue CMS over Medicaid work requirements, asking a court to pause penalties

The state attorneys general argue that the Medicaid work requirements may be unconstitutional, in violation of governmental sovereignty, as they effectively transform the safety net healthcare program into something administered by the federal government.

READ MORE >
Oregon state house Salem
Share on Twitter Share on Facebook Share on Linkedin

Four states sue CMS over Medicaid work requirements, asking a court to pause penalties

Share on Twitter Share on Facebook Share on Linkedin
Oregon state house Salem
The state attorneys general argue that the Medicaid work requirements may be unconstitutional, in violation of governmental sovereignty, as they effectively transform the safety net healthcare program into something administered by the federal government.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup